Integrating HPV Vaccination into Postpartum Care Could Boost Cancer Prevention Efforts, Review Shows Medha Baranwal8 Oct 2024 8:00 PM ISTUSA: Integrating human papillomavirus (HPV) vaccination into routine postpartum care offers a valuable opportunity to reach at-risk patient...
WHO Announces Fourth HPV Vaccine for Use in Single Dose Schedule Dr. Bhumika Maikhuri8 Oct 2024 8:30 AM ISTWHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule....
HPV vaccination switch to 1-dose gender-neutral approach may help eliminate cervical cancer, finds study Dr. Kamal Kant Kohli7 Oct 2024 11:30 PM ISTCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer,...
MMR Vaccine Most Effective Against Measles but May Wane Over Time: Lancet Public Health Dr. Bhumika Maikhuri30 Sept 2024 8:15 AM ISTBetween 2011 and 2019, the proportion of measles cases in adults who received two doses of the MMR vaccine in England increased from 1.9% (20/1064)...
MIT Study Shows That Two Dose Schedule May Make HIV Vaccine More Effective Dr. Bhumika Maikhuri24 Sept 2024 8:45 AM ISTIn a new study, the researchers have now found that they can achieve an immune response similar to multidose regimen, with just two doses, given one...
FDA approves first self administered flu vaccine as nasal spray Dr. Kamal Kant Kohli22 Sept 2024 9:00 PM ISTThe US Food and Drug Administration has approved first self- or caregiver-administered flu vaccine FluMist.FluMist is approved for the prevention of...
WHO Prequalifies The First Vaccine Against Mpox Dr. Bhumika Maikhuri18 Sept 2024 8:00 AM ISTThe World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.“This...
Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Dr. Garima Soni16 Sept 2024 8:00 AM ISTInterim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid...
Moderna lays out plan to slice research and development spending MD Bureau Team15 Sept 2024 10:45 AM ISTWashington: Shares of Moderna tumbled after the vaccine developer said it was cutting research and development spending and pushed back its time...
Moderna forecasts lower sales next year, shares near four-year low MD Bureau Team14 Sept 2024 11:34 AM ISTLondon: Moderna pushed back its break-even goal by two years on Thursday as it delayed the timeline for developing several key products and predicted...
Bavarian Nordic sees potential to ramp up mpox vaccine capacity MD Bureau Team14 Sept 2024 9:15 AM ISTCopenhagen: Bavarian Nordic said on Thursday it could supply 13 million doses of its mpox vaccine by the end of 2025, up from a previous forecast...
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials MD Bureau Team13 Sept 2024 2:56 PM ISTBritish drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the...
